The EU's coming requirement for a machine-readable passport of product data — identity, composition, compliance — resolvable from the product itself.
The Digital Product Passport (DPP), introduced under the EU's Ecodesign for Sustainable Products Regulation, requires products sold in the EU to carry structured, machine-readable data about identity, materials, compliance, and lifecycle — accessible by scanning the product.
Rollout is category by category. The architecture it assumes — a resolvable identifier on the product linking to authoritative, structured data — is exactly the architecture regulated pharma is already building for ePI and serialization.
DPP is not a label change; it requires authoritative product data, kept current, resolvable from a code on the product — with provenance you can defend.
Serialization, GS1 identifiers, and electronic product information mean pharmaceutical companies already run most of the machinery DPP assumes.
Regulators, recyclers, logistics partners, and consumers all read the same passport — the data layer must be trusted by parties with different interests.
The platform's DPP Control Tower maps passport requirements onto the same verified product record used for labelling and traceability — one source, many outputs.
Track DPP readiness per product and market from a single control tower rather than per-department spreadsheets.
A passport read by competitors, regulators, and consumers needs an operator none of them control. A member-governed nonprofit is that operator.
30-minute implementation-readiness consultation with a PLA platform specialist. No procurement, no NDA.
